1. Home
  2. SPE vs ELTX Comparison

SPE vs ELTX Comparison

Compare SPE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Special Opportunities Fund Inc

SPE

Special Opportunities Fund Inc

HOLD

Current Price

$15.12

Market Cap

166.0M

Sector

Finance

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$9.33

Market Cap

158.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPE
ELTX
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.0M
158.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SPE
ELTX
Price
$15.12
$9.33
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
25.4K
106.0K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
8.55%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.26
$4.60
52 Week High
$12.59
$12.62

Technical Indicators

Market Signals
Indicator
SPE
ELTX
Relative Strength Index (RSI) 54.23 54.27
Support Level $15.15 $7.87
Resistance Level $15.19 $8.99
Average True Range (ATR) 0.23 0.49
MACD 0.00 0.12
Stochastic Oscillator 61.42 88.99

Price Performance

Historical Comparison
SPE
ELTX

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: